- Country: Saudi Arabia
- Summary: Supply of Medicines
- SAT Ref No: 74656282
- Deadline: 22 Nov 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: NDP0535/22
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tenders are invited for Supply of Medicines Dexamethasone 0.1% (1 Mg/Ml) + Neomycin Sulphate 3500 Iu/Ml + Polymyxin B Sulphate 6000 Iu/Ml Eye Drops Ophthalmic Bt 500 Candesartan Cilexetil 8 Mg Tablet Oral Tab 175,000 Fenofibrate 200 Mg Tablet Oral Tab 100,020 Nifedipine 60 Mg Tablet Oral Modified Release Tab 140,020 Warfarin Sodium 1 Mg Tablet Oral Tab 45,000 Warfarin Sodium 5 Mg Tablet Oral Tab 40,000 Celecoxib 200 Mg Capsule Oral Cap 15,000 Esomeprazole 20 Mg Tablet Oral Tab 300,048 Esomeprazole 40 Mg Tablet Oral Tab 200,032 Carbimazole 5 Mg Tablet Oral Tab 180,000 [Disclaimer: The above text is machine translated. For accurate information kindly refer the original document.]
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINSupply of Medicines - Saudiarabia Tender
The NATIONAL UNIFIED PROCUREMENT COMPANY, a Government sector organization in Saudi Arabia, has announced a new tender for Supply of Medicines. This tender is published on SaudiarabiaTenders under SAT Ref No: 74656282 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-11-22.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
